Teton Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Teton Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-3,783	Closed	-$201K	–	522
2013 Q4	$201K	Buy	+3,783	New	+$193K	0.01%	481

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Teton Advisors's BMY Position: Q1 2014 in Review

Teton Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2014, closing a stake of 3,783 shares — an estimated $201K sold.

Teton Advisors first reported a position in BMY in Q4 2013 and held it in 1 quarter. The position peaked at $201K in Q4 2013. 1,328 funds tracked by Wall St. Rank hold BMY as of Q1 2014.

Teton Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2014 after selling out during the quarter.
Teton Advisors sold 3,783 Bristol-Myers Squibb shares in Q1 2014, an estimated $201K.
Teton Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 1 quarter.
Teton Advisors's Bristol-Myers Squibb position peaked at $201K in Q4 2013.
1,328 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2014.

Based on Teton Advisors's 13F filing for Q1 2014, filed 2 May 2014.